Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

NCT07218133 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-20

No results posted yet for this study

Summary

This study is a randomized controlled trial that will evaluate the effect of non-invasive auricular vagal nerve stimulation on inflammatory markers, glycemic control, postoperative pain, and inflammation-related clinical outcomes after long-segment spinal fusion surgeries when compared to current accepted management.

Conditions

  • Spinal Fusion
  • Hyperglycemia
  • Postoperative Pain Management
  • Postoperative Care
  • Spine Disease
  • Neurologic Deficits
  • Neurological Disorder
  • Inflammation
  • Spine Condition
  • Spinal (Fusion) Surgery
  • Cytokine Levels
  • Spine Fusion

Interventions

DEVICE

Auricular vagus nerve stimulation

Transcutaneous auricular vagal nerve stimulation

DEVICE

Sham Auricular Vagus nerve Stimulation

Transcutaneous auricular vagal nerve stimulator applied without utilizing stimulating current.

Sponsors & Collaborators

  • Alexander T. Yahanda

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-08
Primary Completion
2026-05-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07218133 on ClinicalTrials.gov